ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+36.8%
5Y CAGR+37.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+36.8%/yr
vs +29.5%/yr prior
5Y CAGR
+37.4%/yr
Consistent
Acceleration
+7.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.9x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $317.75M | +27.3% |
| 2024 | $249.64M | +54.4% |
| 2023 | $161.70M | +30.4% |
| 2022 | $124.04M | +47.2% |
| 2021 | $84.29M | +29.7% |
| 2020 | $64.99M | +16.4% |
| 2019 | $55.84M | +26.7% |
| 2018 | $44.06M | +39.5% |
| 2017 | $31.58M | +13.5% |
| 2016 | $27.83M | - |